secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantheus Holdings, Inc. (LNTH)
CIK:        0001521036
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001193125-26-073439
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantheus Q4 revenue $406.8M, adj EPS $1.67; narrows focus to PET radiodiagnostics
--------------------------------------------------------------------------------

- Worldwide revenue $406.8M (+4% YoY); FY2025 revenue $1.54B; GAAP diluted EPS $0.82 Q4, $3.41 FY.
- Adjusted diluted EPS $1.67 Q4 (+4.7% YoY), $6.08 FY; PYLARIFY sales $240.2M (-9.7%).
- Company sharpens focus on innovative PET radiodiagnostics; pursuing alternatives for radiotherapeutic assets; completed SPECT divestiture to SHINE.
- FY2026 guidance: revenue $1.4B-$1.45B, adjusted diluted EPS $5.00-$5.25.
- Repurchased $100M of stock in Q4; cash and equivalents $359.1M after acquisitions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1521036/000119312526073439/0001193125-26-073439-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1521036/000119312526073439/lnth-20260226.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-073439

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer